HOME > Business Wire > Article
Delta-Fly Pharma Inc.: Notice of Authorization to Conduct the Phase I/II Study of DFP-10917 combined with Venetoclax
TOKUSHIMA, Japan--( BUSINESS WIRE )-- Following to the previous information on March 11th, 2024, we are excited to share our latest development status.
We are pleased to announce the protocol for the Phase I/II clinical trial of DFP-10917 combined with Venetoclax (VTX) in patients with acute myeloid leukemia (AML) with prior VTX involved one regimen, which was submitted to the FDA in US on March 8 has been approved by the FDA in US dated April 8, 2024. Accordingly, we can start the Phase I/II combo-study very soon.
The aim for conducting this study is to judge if DFP-10917 combined with VTX is to show superiority to the standard chemotherapy (azacitidine combined with VTX) for AML. This combo-study shall be done by major clinical sites in US like Wake Forest University, expertise with clinical study of novel chemotherapy for AML.
The interim analysis of the Phase III trial of DFP-10917 monotherapy in patients with recurrent or refractory AML is under follow-up for a number of long-term survivors that have a significant impact on the overall survival (OS) analysis.
Please take notice of our own innovative approach for miserable cancer patients and contact with us.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240408884304/en/
Contacts
Inquiries
Scott Frank
Vice President for Business Development
Delta-Fly Pharma, Inc.
Head office: Tokushima 771-0117, Japan
Phone: +81-3-6231-1278
E-mail:
sfrank1206@delta-flypharma.co.jp
Home page:
https://www.delta-flypharma.co.jp/en/
Source: Delta-Fly Pharma Inc.
Business Wire
- 04/23 07:31 The 2024 Japan Prize Award Ceremony Is Held with Their Majesties the E...
- 04/23 06:15 Nidec Announces Financial Results for Fiscal Year Ended March 31, 2024
- 04/23 03:56 Kioxia Sampling Latest Generation UFS Ver. 4.0 Embedded Flash Memory D...
- 04/23 01:00 Quectel showcases IoT offering at Japan IT Week Spring in Tokyo
- 04/22 16:15 Nexon’s Highly Anticipated Dungeon&Fighter Mobile to Launch in C...
- 04/22 12:12 Lantern Pharma Receives Regulatory Approval to Expand Harmonic™ Clin...
- 04/22 10:46 Foam Molded Product made from KANEKA Biodegradable Polymer Green Plane...
- 04/22 09:00 AI Medical Service Inc. Completes First Pharmaceutical Registration of...
- 04/22 09:00 AI Medical Service Inc. Signs Joint Research Agreement with Mahidol Un...
- 04/22 08:58 Toyoda Gosei Develops UV-C LED with World-Class Light Output
- 04/22 06:00 The Government of Mongolia and The Nature Conservancy Secure ‘Eterna...
- 04/19 02:00 The AGC Group Makes Donations to Help Victims of Eastern Taiwan Earthq...
- 04/19 00:30 La Jolla Institute for Immunology and RevolKa started a Research Colla...
- 04/18 23:00 U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® ...
- 04/18 16:00 OKI Group Revises OKI Group Environmental Vision 2030/2050
- 04/18 12:00 Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s L...
- 04/18 11:30 ReNew partners with JERA to evaluate Joint Development of Green Ammoni...
- 04/18 08:00 Faraday Partners with Arm to Innovate AI-driven Vehicle ASICs
- 04/18 07:00 SiAT Partners with Zeon to Launch Innovative SWCNT Conductive Paste, E...
- 04/18 01:39 Interactive Brokers Launches Global Contracts for Difference (CFDs) in...
- 04/18 01:00 CF Industries and JERA Announce Joint Development Agreement to Develop...
- 04/17 23:01 The Office of Health Economics: Adult Vaccination Programmes Deliver S...
- 04/17 13:56 One Equity Partners Closes Sale of Walki to Japan’s Oji Group
- 04/17 13:25 Opn Announces Appointment of Vaden C. Landers as President and CEO of ...
- 04/17 12:00 Sumitomo Mitsui Trust Asset Management Adopts DTCC’s ITP Services as...
- 04/16 14:00 Dreamtonics Announces Vocoflex, a New Voice Morphing Tool That Creates...
- 04/16 12:00 Bandai Co., Ltd. Partners With Xsolla to Launch the "Tamaverse Ticket ...
- 04/16 12:00 BostonGene and Saga University Announce Collaboration to Uncover Bioma...
- 04/16 10:58 Nominations open for The MIDORI Prize for Biodiversity 2024
- 04/15 19:16 Argonne and RIKEN Sign a Memorandum of Understanding in Support of AI ...